Goodin S - Search Results

1

Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.

Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA. Lindley C, et al. Among authors: goodin s. Am J Clin Oncol. 2005 Jun;28(3):270-6. doi: 10.1097/01.coc.0000145983.35929.2a. Am J Clin Oncol. 2005. PMID: 15923800 Clinical Trial.

2

Epothilones: mechanism of action and biologic activity.

Goodin S, Kane MP, Rubin EH. Goodin S, et al. J Clin Oncol. 2004 May 15;22(10):2015-25. doi: 10.1200/JCO.2004.12.001. J Clin Oncol. 2004. PMID: 15143095 Review.

3

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer.

Goodin S, Rao KV, Kane M, Dave N, Capanna T, Doyle-Lindrud S, Engle E, Jin L, Todd M, DiPaola RS. Goodin S, et al. Cancer Chemother Pharmacol. 2005 Aug;56(2):199-204. doi: 10.1007/s00280-004-0980-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838657 Clinical Trial.

4

Clinical and biological activity of soy protein powder supplementation in healthy male volunteers.

Goodin S, Shen F, Shih WJ, Dave N, Kane MP, Medina P, Lambert GH, Aisner J, Gallo M, DiPaola RS. Goodin S, et al. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):829-33. doi: 10.1158/1055-9965.EPI-06-0882. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416779

5

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer.

Stein M, Goodin S, Doyle-Lindrud S, Silberberg J, Kane M, Metzger D, Eddy S, Shih W, DiPaola RS. Stein M, et al. Among authors: goodin s. Med Sci Monit. 2012 Apr;18(4):CR260-4. doi: 10.12659/msm.882626. Med Sci Monit. 2012. PMID: 22460098 Free PMC article. Clinical Trial.

6

Ixabepilone, a new treatment option for metastatic breast cancer.

Toppmeyer DL, Goodin S. Toppmeyer DL, et al. Among authors: goodin s. Am J Clin Oncol. 2010 Oct;33(5):516-21. doi: 10.1097/COC.0b013e3181b9cd52. Am J Clin Oncol. 2010. PMID: 20023567 Review.

7

5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile.

Goodin S, Cunningham R. Goodin S, et al. Oncologist. 2002;7(5):424-36. doi: 10.1634/theoncologist.7-5-424. Oncologist. 2002. PMID: 12401905 Free article. Review.

8

Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate.

Kumar P, Perrotti M, Weiss R, Todd M, Goodin S, Cummings K, DiPaola RS. Kumar P, et al. Among authors: goodin s. J Clin Oncol. 2004 May 15;22(10):1909-15. doi: 10.1200/JCO.2004.02.001. J Clin Oncol. 2004. PMID: 15143084 Clinical Trial.

9

Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.

DiPaola RS, Rafi MM, Vyas V, Toppmeyer D, Rubin E, Patel J, Goodin S, Medina M, Medina P, Zamek R, Zhang C, White E, Gupta E, Hait WN. DiPaola RS, et al. Among authors: goodin s. J Clin Oncol. 1999 Jul;17(7):2213-8. doi: 10.1200/JCO.1999.17.7.2213. J Clin Oncol. 1999. PMID: 10561278 Clinical Trial.

10

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer.

Goodin S, Medina P, Capanna T, Shih WJ, Abraham S, Winnie J, Doyle-Lindrud S, Todd M, DiPaola RS. Goodin S, et al. J Clin Oncol. 2005 May 20;23(15):3352-7. doi: 10.1200/JCO.2005.11.111. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters